The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney disease

被引：1
|
作者：
Lee, Gavin [1 ]
Krishnasamy, Rathika [1 ,2 ]
Hawley, Carmel M. [1 ,2 ,3 ]
Johnson, David W. [1 ,2 ,3 ]
机构：
[1] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld, Australia
[3] Translat Res Inst, Brisbane, Qld, Australia
来源：
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM | 2015年 / 10卷 / 06期
关键词：
cardiovascular disease; chronic kidney disease; endothelial function; fibroblast growth factor-23; klotho; left ventricular hypertrophy; secondary hyperparathyroidism; vascular calcification;
D O I：
10.1586/17446651.2015.1079124
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Chronic kidney disease is associated with an accelerated risk of cardiovascular (CV) mortality. Seminal work over the last decade has identified abnormal bone metabolism as an important modulator of the increased CV burden in this cohort. In particular, FGF23, a phosphaturic hormone with serum levels found to be markedly elevated in chronic kidney disease, is independently associated with increased risks of all-cause mortality and CV events. This editorial will discuss the proposed mechanisms linking FGF23 to CV disease in chronic kidney disease, namely, direct cardiac myocyte toxicity, endothelial dysfunction and vascular calcification.
引用
收藏
页码：565 / 568
页数：4
相关论文
共 50 条
  • [31] Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?
    Bernhard Bielesz
    Wiener klinische Wochenschrift, 2010, 122 : 194 - 197
  • [32] Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II
    Pi, Min
    Ye, Ruisong
    Han, Xiaobin
    Armstrong, Benjamin
    Liu, Xue
    Chen, Yuanjian
    Sun, Yao
    Quarles, L. Darryl
    SCIENTIFIC REPORTS, 2018, 8
  • [33] Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney Failure
    Wolf, Myles
    Mehta, Rupal
    JACC-HEART FAILURE, 2015, 3 (10) : 840 - 842
  • [34] The Role of Fibroblast Growth Factor-23 in Cardiorenal Syndrome
    Kovesdy, Csaba P.
    Quarles, L. Darryl
    NEPHRON CLINICAL PRACTICE, 2013, 123 (3-4): : 194 - 201
  • [35] Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
    Arnlov, Johan
    Carlsson, Axel C.
    Sundstrom, Johan
    Ingelsson, Erik
    Larsson, Anders
    Lind, Lars
    Larsson, Tobias E.
    KIDNEY INTERNATIONAL, 2013, 83 (01) : 160 - 166
  • [36] Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease
    Bouma-de Krijger, Annet
    Bots, Michiel L.
    Vervloet, Marc G.
    Blankestijn, Peter J.
    ter Wee, Pieter W.
    van Zuilen, Arjan D.
    Wetzels, Jack F.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (01) : 88 - 97
  • [37] Fibroblast growth factor-23 and fetuin-A in black South African children with chronic kidney disease
    Mudi, A.
    Dickens, C.
    Duarte, R.
    Ballot, D.
    Levy, C.
    SOUTH AFRICAN JOURNAL OF CHILD HEALTH, 2020, 14 (03) : 139 - 143
  • [38] Serum Klotho: Relation to Fibroblast Growth Factor-23 and Other Regulators of Phosphate Metabolism in Children with Chronic Kidney Disease
    Sawires, Happy K.
    Essam, Rasha M.
    Morgan, Marian F.
    Mahmoud, Rasha A.
    NEPHRON, 2015, 129 (04) : 293 - 299
  • [39] Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease
    Dzgoeva, F. U.
    Gatagonova, T. M.
    Bestaeva, T. L.
    Sopoev, M. Yu.
    Bazaeva, B. G.
    Khamitsaeva, O. V.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (06) : 63 - 69
  • [40] Fibroblast Growth Factor 23 Level and Cardiovascular Parameters in Children with Chronic Kidney Disease
    Gaurav Singh
    Om P. Mishra
    Abhishek Abhinay
    Vikas Agarwal
    Surendra P. Mishra
    Amitnandan D. Dwivedi
    Ankur Singh
    Rajniti Prasad
    Rabindra N. Mishra
    Indian Journal of Pediatrics, 2022, 89 : 865 - 871
12345